Patten Group’s GSK GSK Stock Holding History

Patten Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,319	Closed	-$234K	–	241
2022 Q2	$234K	Buy	4,319 +240	+6%	+$13.2K	0.08%	217
2022 Q1	$222K	Buy	+4,079	New	+$222K	0.06%	244
2019 Q1	–	Sell	-664	Closed	-$32K	–	333
2018 Q4	$32K	Hold	664	–	–	0.02%	332
2018 Q3	$33K	Hold	664	–	–	0.01%	373
2018 Q2	$33K	Hold	664	–	–	0.01%	364
2018 Q1	$32K	Hold	664	–	–	0.01%	362
2017 Q4	$29K	Hold	664	–	–	0.01%	391
2017 Q3	$34K	Hold	664	–	–	0.01%	367
2017 Q2	$34K	Hold	664	–	–	0.01%	369
2017 Q1	$34K	Hold	664	–	–	0.01%	347
2016 Q4	$32K	Sell	664 -2,012	-75%	-$99.4K	0.01%	346
2016 Q3	$142K	Buy	2,676 +908	+51%	+$49.8K	0.07%	203
2016 Q2	$95.8K	Buy	1,768 +304	+21%	+$16K	0.04%	240
2016 Q1	$74.2K	Hold	1,464	–	–	0.04%	259
2015 Q4	$73.8K	Buy	1,464 +1,000	+216%	+$51K	0.04%	263
2015 Q3	$22.3K	Hold	464	–	–	0.01%	357
2015 Q2	$24.2K	Buy	+464	New	+$26.1K	0.01%	358

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Patten Group's GSK Position: Q3 2022 in Review

Patten Group sold out of GSK (GSK) in Q3 2022, closing a stake of 4,319 shares — an estimated $234K sold.

Patten Group first reported a position in GSK in Q2 2015 and held it in 17 quarters. The position peaked at $234K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Patten Group reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Patten Group sold 4,319 GSK shares in Q3 2022, an estimated $234K.
Patten Group first reported a position in GSK in Q2 2015 and held it in 17 quarters.
Patten Group's GSK position peaked at $234K in Q2 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Patten Group's 13F filing for Q3 2022, filed 13 Oct 2022.